Biotech Nephrogen combines AI and gene therapy to reverse kidney disease — check it out at TechCrunch Disrupt 2025

Discover how Biotech Nephrogen is revolutionizing kidney disease treatment using a cutting-edge combination of AI and gene therapy. Dive into their groundbreaking approach showcased at TechCrunch Disrupt 2025. Learn how Demetri Maxim's personal experience with his mother's kidney disease inspired this innovative solution that could potentially change the lives of millions. Explore the fascinating intersection of technology and healthcare as Biotech Nephrogen aims to reverse kidney disease and offer hope to those in need. Join the journey towards a future where advanced biotech solutions pave the way for improved quality of life and better health outcomes.

Read More

Bookmark and Share